154 related articles for article (PubMed ID: 34530564)
1. [Endoscopic marking of upper tumor resection margin and lymphatic drainage before neoadjuvant chemotherapy in Siewert type II adenocarcinoma of esophagogastric junction].
Cao YH; Zhang JL; Ma PF; Liu CY; Li S; Zhang XJ; Han GS; Zhao YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):819-822. PubMed ID: 34530564
[No Abstract] [Full Text] [Related]
2. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of positive circumferential resection margin post neoadjuvant chemotherapy in patients with esophageal or gastro-esophageal junction adenocarcinoma.
Patrão AS; Papaxoinis G; Kordatou Z; Weaver JM; Owen-Holt V; Alkhaffaf B; Galloway S; Mansoor W
Eur J Surg Oncol; 2019 Mar; 45(3):439-445. PubMed ID: 30786962
[TBL] [Abstract][Full Text] [Related]
4. Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature.
Niclauss N; Jung MK; Chevallay M; Mönig SP
Updates Surg; 2019 Sep; 71(3):401-409. PubMed ID: 31243725
[TBL] [Abstract][Full Text] [Related]
5. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
6. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
7. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
[TBL] [Abstract][Full Text] [Related]
8. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach.
Kumar NA; Desouza A; Bhandare MS; Murugan JR; Khandelwal G; Chaudhari V; Ostwal V; Shrikhande SV
Langenbecks Arch Surg; 2021 May; 406(3):613-621. PubMed ID: 33242137
[TBL] [Abstract][Full Text] [Related]
9. What Is the Best Operation for Proximal Gastric Cancer and Distal Esophageal Cancer?
Mazer LM; Poultsides GA
Surg Clin North Am; 2019 Jun; 99(3):457-469. PubMed ID: 31047035
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and Safety of Transhiatal Approach and D2 Total Gastrectomy after Neoadjuvant Chemotherapy for Adenocarcinoma of the Esophago-Gastric Junction: A Subset Analysis of the COMPASS Trial.
Yoshikawa T; Aoyama T; Tanabe K; Nishikawa K; Ito Y; Hayashi T; Cho H; Miyashita Y; Tsuburaya A; Sakamoto J
Dig Surg; 2016; 33(5):424-30. PubMed ID: 27164988
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of laparoscopic-assisted and open total gastrectomy for Siewert Types II and III adenocarcinoma of the esophagogastric junction.
Wang J; Wang JC; Song B; Dai XD; Zhang XY
J Cell Physiol; 2019 Jul; 234(7):11235-11239. PubMed ID: 30478913
[TBL] [Abstract][Full Text] [Related]
12. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
13. [Surgical strategy for adenocarcinoma of esophagogastric junction].
Lu Y; Zhang K; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532
[TBL] [Abstract][Full Text] [Related]
14. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Polkowski WP; van Lanschot JJ
Br J Surg; 2014 May; 101(6):735. PubMed ID: 24723025
[No Abstract] [Full Text] [Related]
15. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
16. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
[TBL] [Abstract][Full Text] [Related]
17. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].
Yan Q; Lyu ZJ; Zheng JB; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000
[TBL] [Abstract][Full Text] [Related]
18. Authors' reply: Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction (Br J Surg 2013; 100: 1050-1054).
Mine S; Sano T
Br J Surg; 2014 May; 101(6):735-6. PubMed ID: 24723024
[No Abstract] [Full Text] [Related]
19. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
[TBL] [Abstract][Full Text] [Related]
20. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
